The Paragon Report Provides Stock Research on ImmunoGen and Orexigen Therapeutics
Continue ReadingTag: research-reports
New Enzyme Allows Ethanol Producers to Make 2.5% More Ethanol From Corn
The Paragon Report Provides Stock Research on BioFuel Energy and Renewable Energy Group
Continue ReadingFDA Considering Faster Pathway for Obesity Treatments, Life-Saving Antibiotics and Other Drugs Deemed to Offer Societal Benefit
The Paragon Report Provides Stock Research on Arena Pharmaceuticals and VIVUS
Continue ReadingFDA Considering Allowing Developers of Critical Drugs/Treatments to Conduct Smaller, Faster Clinical Trials
The Paragon Report Provides Stock Research on Achillion Pharmaceuticals and Halozyme Therapeutics
Continue ReadingFDA Considering Faster Approval Process for Developers of Drugs for Deadly or Debilitating Diseases
The Paragon Report Provides Stock Research on Novavax and Cardium Therapeutics
Continue ReadingSmaller, Faster Clinical Trials Considered by the FDA for Developers of Critical Drugs and Treatments
The Paragon Report Provides Stock Research on Ariad Pharmaceuticals and Galena Biopharma
Continue ReadingCollective Third Quarter Profits of the S&P 500 Index Expected to Decline
Five Star Equities Provides Stock Research on Amazon.com and Caterpillar
Continue ReadingCritical Drugs Deemed to Offer Societal Benefit Could See Fast FDA Approval Process
The Paragon Report Provides Stock Research on PDL BioPharma and Sequenom
Continue ReadingMajor Banks Benefitting From Improved Mortgage Profit Margins
The Paragon Report Provides Stock Research on Bank of America and Citigroup
Continue ReadingJames River Coal and Patriot Coal Shares Rally as Metallurgical Coal Demand Speculated to Rise
Five Star Equities Provides Stock Research on James River Coal and Patriot Coal
Continue Reading